| Company Name: | AdvanSource Biomaterials Corporation | | Ticker Symbol: | ASB | | | WWW Address: | www.advbiomaterials.com |
| CEO: | Michael F. Adams | | No. of Employees: | 19 |
| Common Issue Type: | CS | | Business Description: | AdvanSource Biomaterials Corporation develops advanced polymer materials, which provide critical characteristics in the design and development of medical devices.
|
| | | Industry Information: | HEALTH SERVICES - Medical Instruments & Supplies [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 0.2 |  0.0 | - | - | | 0.20 | 0.18 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 4.2 | 21.2 | 0.97 | -0.08 | 0.00 | 0.0 | 0.0 | 0.44 - 0.12 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 0.12 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 4.2 | mil |
| Latest Shares Outstanding | 42.0 | mil |
| Earnings pS (EPS) | -7.40 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 307,537 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 26.9 | mil |
| Float as % of Shares Outstanding | 64.2 | % |
| Foreign Sales | 26 | mil |
| Domestic Sales | 74 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 30.80 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 25.0 | % |
| EBITDA Margin | -5.8 | % |
| Pre-Tax Profit Margin | -52.2 | % |
| Assets Turnover | 0.8 | % |
| Return on Assets (ROA) | -41.9 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | 128.8 | % |
| Current Ratio | 0.2 | |
| Leverage Ratio (Assets/Equity) | 0.0 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | -5.37 | $ |
| Cash pS | 0.02 | $ |
| Book-Value pS | 0.00 | $ |
| Tangible Book-Value pS | -4.94 | $ |
| Cash Flow pS | -1.86 | $ |
| Free Cash Flow pS | -3.05 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 0.00 | |
| Price/Tangible Book Ratio | -0.02 | |
| Price/Cash Flow | -0.1 | |
| Price/Free Cash Flow | 0.0 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -14.3 | 89 | 802 | 1,016 |
| 4 Weeks | 0.22 | 0.09 | 0.18 | -33.3 | 70 | 756 | 12,088 |
| 13 Weeks | 0.38 | 0.05 | 0.40 | -70.0 | 33 | 653 | 37,845 |
| 26 Weeks | 1.09 | 0.05 | 1.00 | -88.0 | 13 | 428 | 52,242 |
| 52 Weeks | 2.54 | 0.05 | 2.10 | -94.3 | 6 | 324 | 80,439 |
| YTD | 0.25 | 0.09 | - | -50.0 | 55 | 763 | 18,313 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 0.14 | 0.14 | 0.18 | 0.55 | 0.82 | 3.38 | 1.86 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 137.13 | 64.9 | 337.21 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 419.15 | NA | 1530.79 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 53.7 | 38.8 | 25.2 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.45 | 0.32 | -5.34 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 12.27 |
| Current Ratio | 2.2 |
| Quick Ratio (Acid Test) | 0.6 |
| Liquidity Ratio (Cash) | 0.15 |
| Receivables Turnover | 10.4 |
| Average Collection Period | 35 |
| Working Capital/Equity | -34.5 |
| Working Capital pS | 0.72 |
| Cash-Flow pS | -2.61 |
| Free Cash-Flow pS | -2.91 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | -0.91 |
| Financial Leverage Ratio (Assets/Equity) | 0.0 |
| Debt Ratio | 135.6 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 140.1 |
| LT Debt/Total Liabilities | 92.3 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 5.89 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 66.58 |
| Tobin's Q Ratio | 0.02 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | -50.23 |
| Enterprise Value (EV)/Free Cash Flow | -0.95 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -0.02 |
| Price/Book Ratio - LTM | 0.00 |
| Price/Cash Flow Ratio | -0.1 |
| Price/Free Cash Flow Ratio - LTM | 0.0 |
| Price/Sales Ratio | 0.04 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.3 |
| PER SHARE FIGURES |
| LT Debt pS | 7.38 |
| Current Liabilities pS | 0.60 |
| Tangible Book Value pS - LTM | -4.94 |
| Book Value pS - LTM | 0.00 |
| Capital Invested pS | 4.63 |
| Cash pS - LTM | 0.02 |
| Cash Flow pS - LTM | -1.86 |
| Free Cash Flow pS - LTM | -3.05 |
| Earnings pS (EPS) | -7.40 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -107.41 |
| Free Cash Flow Margin 5YEAR AVG | -58.15 |
| Net Profit Margin | 0.0 |
| Net Profit Margin - 5YEAR AVRG. | -74.9 |
| Equity Productivity | -1.29 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 0.51 |
| Return on Capital Invested (ROCI) | -53.4 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -66.5 |
| Assets Productivity | 0.60 |
| Return on Assets (ROA) | -47.8 |
| Return on Assets (ROA) - 5YEAR AVRG. | -41.6 |
| Gross Profit Margin | 25.0 |
| Gross Profit Margin - 5YEAR AVRG. | 19.4 |
| EBITDA Margin - LTM | -5.8 |
| EBIT Margin - LTM | -36.0 |
| Pre-Tax Profit Margin | -80.6 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -62.2 |
| Effective Tax Rate | 0.0 |
| Effective Tax Rate - 5YEAR AVRG. | 1.4 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 141 |
| Revenue per Employee | 307,537 |
| Net Income per Employee | -319,762 |
| Average Collection Period | 40 |
| Receivables Turnover | 10.4 |
| Day's Inventory Turnover Ratio | 101 |
| Inventory Turnover | 3.5 |
| Inventory/Sales | 28.7 |
| Accounts Payble/Sales | 8.98 |
| Assets/Revenue | 1.67 |
| Net Working Capital Turnover | 3.74 |
| Fixed Assets Turnover | 0.59 |
| Total Assets Turnover | 0.6 |
| Revenue per $ Cash | 30.17 |
| Revenue per $ Plant | 15.33 |
| Revenue per $ Common Equity | -1.29 |
| Revenue per $ Capital Invested | 0.51 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 25.9 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 28.0 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |
